+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Italy In-Vitro Diagnostics Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

  • PDF Icon

    Report

  • 180 Pages
  • May 2023
  • Region: Italy
  • Renub Research
  • ID: 5802231

Italy in-vitro Diagnostics Market was US$ 2.44 Billion in 2022

Italy In-Vitro Diagnostics Market will reach US$ 3.59 Billion in 2028, according to the publisher. In vitro means 'in glass,' indicating that the tests are conducted in controlled laboratory conditions rather than within a living organism. IVD, or In Vitro Diagnostics, are medical tests performed in a lab on samples like blood or urine. They help diagnose diseases, monitor treatment progress, and provide health information. IVD encompasses various tests like clinical chemistry, immunoassays, molecular diagnostics, microbiology, hematology, and histopathology. Common examples include glucose monitoring, cholesterol testing, pregnancy tests, HIV testing, genetic testing, and cancer biomarker analysis. IVD is vital for disease screening, early detection, patient management, and treatment monitoring, leading to improved outcomes and personalized medicine.

Italy In-Vitro Diagnostics Market shall grow at a CAGR of 6.65% during the forecast period of 2022 to 2028

The rising number of cases of chronic and infectious diseases and the aging population majorly add to Italy in-vitro diagnostics market growth. The publication titled 'cardiovascular disease (CVD) Burden: Italian and global perspectives,' available on Europe PMC, highlighted that Italy exhibits a substantially higher prevalence of cardiovascular disease (CVD) in comparison to the global average. The report indicates that Italy CVD prevalence is nearly double the global average (12.9% vs. 6.6%), while age-standardized figures show relatively similar rates (6.2% vs. 6.3%).

Additionally, technological advancements, government initiatives, healthcare reforms, growing emphasis on personalized medicine, and increasing awareness and patient empowerment will further improve Italy in-vitro diagnostics market in the future. Hence, the market value for Italy's in-vitro Diagnostics Market was US$ 2.44 Billion in 2022.

Services shall thrive in the Italy in-vitro diagnostics market

Italy's in-vitro diagnostics market is categorized into three product segments: Services, Instruments, and Reagents. Services dominate the Italy in-vitro diagnostics market due to factors such as the complexity of IVD tests and devices, regulatory compliance, training and education needs, customization and integration services, and value-added support. With sophisticated technologies requiring specialized expertise, service providers are relied upon for proper handling and maintenance. In addition, strict regulations ensure patient safety and reliability, increasing the demand for technical services. Providers also offer training programs, customization, and additional support beyond installation and maintenance. These factors collectively drive the leadership of services in Italy in-vitro diagnostics market.

PCR tests shall continue to have the highest market share in the Italy in-vitro diagnostics market

In the Italy in-vitro diagnostics market, there is a range of test types available, including ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, and Others.PCR tests are known for their high sensitivity and specificity, allowing for accurate detection and identification of pathogens or genetic material, contributing to their widespread adoption. PCR technology has many applications beyond infectious disease diagnosis, including genetics and forensics.

PCR tests offer relatively quick turnaround times and have the advantage of being available on various platforms, which facilitates scalability. Furthermore, PCR tests have a long-established track record of diagnostics validity and regulatory approval, which has instilled confidence in healthcare providers. Finally, the COVID-19 pandemic has played a central role in the widespread adoption of PCR tests, further contributing to their high share in the Italy in-vitro diagnostics market.

Infectious diseases application is fastest growing in the Italy In-vitro diagnostics market

In the Italy In-vitro diagnostics market, various applications are of significant importance, including Infectious Diseases, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, and other applications. Increased global travel and migration have facilitated the spread of infectious diseases across borders, making Italy susceptible to their introduction and transmission. Additionally, changing demographics and lifestyle factors, such as urbanization, population density, and high-risk activities, contribute to transmitting infectious agents.

Antimicrobial resistance has also played a significant role, highlighting the need for accurate diagnostics to guide appropriate treatment decisions. Outbreaks and epidemics, such as influenza, measles, and COVID-19, have increased the demand for rapid and accurate diagnostics for timely intervention and public health management. Increased awareness and proactive screening programs have further contributed to the growth, as they help identify infected individuals early and initiate appropriate treatment. Technological advancements, including molecular diagnostics and rapid point-of-care testing, have improved infectious disease diagnostics' capabilities and accuracy, fuelling their market growth.

Molecular Diagnostics/Genetics shall flourish during the forecast period

In the Italy In-vitro diagnostics market, various technologies are utilized, including Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, and other technologies. Technological advancements like PCR, NGS, and gene expression profiling have improved genetic testing accuracy and accessibility. A greater understanding of genetics in disease development has increased the demand for molecular diagnostics. Precision medicine tailors’ treatment based on genetics, biomarkers, and disease characteristics, contributing to growth.

In cancer diagnostics, molecular diagnostics enable early detection, accurate diagnosis, and personalized treatment plans. Government initiatives support molecular diagnostics adoption through research investment and reimbursement policies. The rising demand for early disease detection and prevention fuels molecular diagnostics growth in the market. These factors drive growth, enhancing diagnostics capabilities and personalized medicine approaches, especially in cancer diagnostics.

Hospitals continue to have sovereignty in the Italy In-vitro diagnostics market

Segmentation of Italy's in-vitro diagnostics market based on end-users can break into four divisions: Hospitals, Laboratories, Home-Care, and Other sectors. Hospitals dominate the Italy in-vitro diagnostics (IVD) market due to their comprehensive healthcare services and seamless integration of diagnostics with other specialties. They possess the necessary infrastructure, resources, and skilled personnel for a robust IVD operation.

Being primary points of care, hospitals offer a wide range of medical services and act as referral centers. Their diverse clinical specialties ensure accurate diagnosis and interpretation of IVD test results. In addition, hospitals benefit from favorable reimbursement and funding mechanisms and adhere to stringent regulatory requirements, ensuring patient safety and test accuracy.

Key Players

In the Italy in-vitro diagnostics market, notable companies include Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation.

In May 2022 - The European Union's new In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR) took effect in Italy on May 26, 2022. While some existing devices are granted transition periods, the IVDR requirements now apply to all new in vitro diagnostics (IVDs) and specific low-risk IVDs already available in the market.

The report titled “Italy in-vitro diagnostics Market Global Forecast by Products (Services, Instruments, and Reagents), Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, and Others), Application (Infectious Diseases, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, and Others), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, and Others), End-Users (Hospitals, Laboratories, Home - Care, and Others), Company Analysis (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation)' provides a detailed analysis of Italy in-vitro Diagnostics Market.

Products - Market breakup from 3 Viewpoints:

1. Services
2. Instruments
3. Reagents

Test types - Market breakup from 11 Viewpoints:

1. ELISA & CLIA
2. PCR
3. Rapid Test
4. Fluorescence Immunoassays (FIA)
5. In Situ Hybridization
6. Transcription Mediated Amplification
7. Sequencing
8. Colorimetric Immunoassay
9. Radioimmunoassay (RIA)
10. Isothermal Nucleic Acid Amplification Technology
11. Others

Application - Market breakup from 8 Viewpoints:

1. Infectious Diseases
2. Diabetes
3. Cardiology
4. Oncology
5. Nephrology
6. Autoimmune Diseases
7. Drug Testing
8. Others

Technology - Market breakup from 7 Viewpoints:

1. Immunoassay
2. Clinical Chemistry
3. Molecular Diagnostics/Genetics
4. Hematology
5. Microbiology
6. Coagulation
7. Others

End-Users - Market breakup from 4 Viewpoints:

1. Hospitals
2. Laboratories
3. Home - Care
4. Others

Company has been covered from 3 Viewpoints:

  • Overview
  • Recent Development
  • Revenue

Company Analysis:

1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
Frequently Asked Questions about the Italian In-Vitro Diagnostics Market

What is the estimated value of the Italian In-Vitro Diagnostics Market?

The Italian In-Vitro Diagnostics Market was estimated to be valued at $2.44 Billion in 2022.

What is the growth rate of the Italian In-Vitro Diagnostics Market?

The growth rate of the Italian In-Vitro Diagnostics Market is 6.6%, with an estimated value of $3.59 Billion by 2028.

What is the forecasted size of the Italian In-Vitro Diagnostics Market?

The Italian In-Vitro Diagnostics Market is estimated to be worth $3.59 Billion by 2028.

Who are the key companies in the Italian In-Vitro Diagnostics Market?

Key companies in the Italian In-Vitro Diagnostics Market include Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific and Sysmex Corporation.

Table of Contents

1. Introduction2. Research & Methodology3. Executive Summary
4. Market Dynamic
4.1 Growth Drivers
4.2 Challenges
5. Porter’s Five Forces
5.1 Bargaining Power of Buyer
5.2 Bargaining Power of Supplier
5.3 Threat of New Entrants
5.4 Rivalry among Existing Competitors
5.5 Threat of Substitute Products
6. SWOT Analysis
6.1 Strengths
6.2 Weaknesses
6.3 Opportunities
6.4 Threats
7. Italy In-Vitro Diagnostics (IVD) Market
8. Market Share - Italy In-Vitro Diagnostics (IVD)
8.1 By Test Types
8.2 By Technology
8.3 By Products
8.4 By Application
8.5 By End User
9. Test Types -Italy In-Vitro Diagnostics (IVD) Market
9.1 ELISA & CLIA
9.2 PCR
9.3 Rapid Test
9.4 Fluorescence Immunoassays (FIA)
9.5 In Situ Hybridization
9.6 Transcription Mediated Amplification
9.7 Sequencing
9.8 Colorimetric Immunoassay
9.9 Radioimmunoassay (RIA)
9.10 Isothermal Nucleic Acid Amplification Technology
9.11 Others
10. Product Types - Italy In-Vitro Diagnostics (IVD) Market
10.1 Services
10.2 Instruments
10.3 Reagents
11. Technology - Italy In-Vitro Diagnostics (IVD) Market
11.1 Immunoassay
11.2 Clinical Chemistry
11.3 Molecular Diagnostics/Genetics
11.4 Hematology
11.5 Microbiology
11.6 Coagulation
11.7 Others
12. Application - Italy In-Vitro Diagnostics (IVD) Market
12.1 Infectious Disease
12.2 Diabetes
12.3 Cardiology
12.4 Oncology
12.5 Nephrology
12.6 Autoimmune Diseases
12.7 Drug Testing
12.8 Other Applications
13. End User - Italy In-Vitro Diagnostics (IVD) Market
13.1 Hospitals
13.2 Laboratories
13.3 Home-Care
13.4 Others
14. Government Rules & Regulation
15. Reimbursement
15.1 Public
15.2 Private & Insurance
16. Company Analysis
16.1 Roche Diagnostics
16.1.1 Overview
16.1.2 Resent Development
16.1.3 Revenue
16.2 Abbott Diagnostics
16.2.1 Overview
16.2.2 Resent Development
16.2.3 Revenue
16.3 Siemens Healthineers
16.3.1 Overview
16.3.2 Resent Development
16.3.3 Revenue
16.4 Danaher Corporation
16.4.1 Overview
16.4.2 Resent Development
16.4.3 Revenue
16.5 Thermo Fisher Scientific
16.5.1 Overview
16.5.2 Resent Development
16.5.3 Revenue
16.6 Sysmex Corporation
16.6.1 Overview
16.6.2 Resent Development
16.6.3 Revenue
List of Figures:
Figure 01: Italy - In-Vitro Diagnostics (IVD) Market (Billion US$), 2018 - 2022
Figure 02: Italy - Forecast for In-Vitro Diagnostics (IVD) Market (Billion US$), 2023 - 2028
Figure 03: Test Types - ELISA & CLIA Market (Million US$), 2018 - 2022
Figure 04: Test Types - Forecast for ELISA & CLIA Market (Million US$), 2023 - 2028
Figure 05: Test Types - PCR Market (Million US$), 2018 - 2022
Figure 06: Test Types - Forecast for PCR Market (Million US$), 2023 - 2028
Figure 07: Test Types - Rapid Test Market (Million US$), 2018 - 2022
Figure 08: Test Types - Forecast for Rapid Test Market (Million US$), 2023 - 2028
Figure 09: Test Types - Fluorescence Immunoassays (FIA) Market (Million US$), 2018 - 2022
Figure 10: Test Types - Forecast for Fluorescence Immunoassays (FIA) Market (Million US$), 2023 - 2028
Figure 11: Test Types - In Situ Hybridization Market (Million US$), 2018 - 2022
Figure 12: Test Types - Forecast for In Situ Hybridization Market (Million US$), 2023 - 2028
Figure 13: Test Types - Transcription Mediated Amplification Market (Million US$), 2018 - 2022
Figure 14: Test Types - Forecast for Transcription Mediated Amplification Market (Million US$), 2023 - 2028
Figure 15: Test Types - Sequencing Market (Million US$), 2018 - 2022
Figure 16: Test Types - Forecast for Sequencing Market (Million US$), 2023 - 2028
Figure 17: Test Types - Colorimetric Immunoassay Market (Million US$), 2018 - 2022
Figure 18: Test Types - Forecast for Colorimetric Immunoassay Market (Million US$), 2023 - 2028
Figure 19: Test Types - Radioimmunoassay (RIA) Market (Million US$), 2018 - 2022
Figure 20: Test Types - Forecast for Radioimmunoassay (RIA) Market (Million US$), 2023 - 2028
Figure 21: Test Types - Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2018 - 2022
Figure 22: Test Types - Forecast for Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2023 - 2028
Figure 23: Test Types - Others Market (Million US$), 2018 - 2022
Figure 24: Test Types - Forecast for Others Market (Million US$), 2023 - 2028
Figure 25: Product Types - Services Market (Million US$), 2018 - 2022
Figure 26: Product Types - Forecast for Services Market (Million US$), 2023 - 2028
Figure 27: Product Types - Instruments Market (Million US$), 2018 - 2022
Figure 28: Product Types - Forecast for Instruments Market (Million US$), 2023 - 2028
Figure 29: Product Types - Reagents Market (Million US$), 2018 - 2022
Figure 30: Product Types - Forecast for Reagents Market (Million US$), 2023 - 2028
Figure 31: Technology - Immunoassay Market (Million US$), 2018 - 2022
Figure 32: Technology - Forecast for Immunoassay Market (Million US$), 2023 - 2028
Figure 33: Technology - Clinical Chemistry Market (Million US$), 2018 - 2022
Figure 34: Technology - Forecast for Clinical Chemistry Market (Million US$), 2023 - 2028
Figure 35: Technology - Molecular Diagnostics/Genetics Market (Million US$), 2018 - 2022
Figure 36: Technology - Forecast for Molecular Diagnostics/Genetics Market (Million US$), 2023 - 2028
Figure 37: Technology - Hematology Market (Million US$), 2018 - 2022
Figure 38: Technology - Forecast for Hematology Market (Million US$), 2023 - 2028
Figure 45: Technology - Microbiology Market (Million US$), 2018 - 2022
Figure 46: Technology - Forecast for Microbiology Market (Million US$), 2023 - 2028
Figure 39: Technology - Coagulation Market (Million US$), 2018 - 2022
Figure 40: Technology - Forecast for Coagulation Market (Million US$), 2023 - 2028
Figure 41: Technology - Others Market (Million US$), 2018 - 2022
Figure 42: Technology - Forecast for Others Market (Million US$), 2023 - 2028
Figure 43: Application - Infectious Disease Market (Million US$), 2018 - 2022
Figure 44: Application - Forecast for Infectious Disease Market (Million US$), 2023 - 2028
Figure 47: Application - Diabetes Market (Million US$), 2018 - 2022
Figure 48: Application - Forecast for Diabetes Market (Million US$), 2023 - 2028
Figure 49: Application - Cardiology Market (Million US$), 2018 - 2022
Figure 50: Application - Forecast for Cardiology Market (Million US$), 2023 - 2028
Figure 51: Application - Oncology Market (Million US$), 2018 - 2022
Figure 52: Application - Forecast for Oncology Market (Million US$), 2023 - 2028
Figure 53: Application - Nephrology Market (Million US$), 2018 - 2022
Figure 54: Application - Forecast for Nephrology Market (Million US$), 2023 - 2028
Figure 55: Application - Autoimmune Diseases Market (Million US$), 2018 - 2022
Figure 56: Application - Forecast for Autoimmune Diseases Market (Million US$), 2023 - 2028
Figure 57: Application - Drug Testing Market (Million US$), 2018 - 2022
Figure 58: Application - Forecast for Drug Testing Market (Million US$), 2023 - 2028
Figure 59: Application - Other Applications Market (Million US$), 2018 - 2022
Figure 60: Application - Forecast for Other Applications Market (Million US$), 2023 - 2028
Figure 61: End User - Hospitals Market (Million US$), 2018 - 2022
Figure 62: End User - Forecast for Hospitals Market (Million US$), 2023 - 2028
Figure 63: End User - Laboratories Market (Million US$), 2018 - 2022
Figure 64: End User - Forecast for Laboratories Market (Million US$), 2023 - 2028
Figure 65: End User - Home-Care Market (Million US$), 2018 - 2022
Figure 66: End User - Forecast for Home-Care Market (Million US$), 2023 - 2028
Figure 67: End User - Others Market (Million US$), 2018 - 2022
Figure 68: End User - Forecast for Others Market (Million US$), 2023 - 2028
Figure 69: Roche Diagnostics - Global Revenue (Billion US$), 2018 - 2022
Figure 70: Roche Diagnostics - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 71: Abbott Diagnostics - Global Revenue (Billion US$), 2018 - 2022
Figure 72: Abbott Diagnostics - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 73: Siemens Healthineers - Global Revenue (Billion US$), 2018 - 2022
Figure 74: Siemens Healthineers - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 75: Danaher Corporation - Global Revenue (Billion US$), 2018 - 2022
Figure 76: Danaher Corporation - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 77: Thermo Fisher Scientific - Global Revenue (Billion US$), 2018 - 2022
Figure 78: Thermo Fisher Scientific - Forecast for Global Revenue (Billion US$), 2023 - 2028
Figure 79: Sysmex Corporation - Global Revenue (Million US$), 2018 - 2022
Figure 80: Sysmex Corporation - Forecast for Global Revenue (Million US$), 2023 - 2028
List of Tables:
Table 01: Italy - In-Vitro Diagnostics (IVD) Market Share by Test Types (Percent), 2018 - 2022
Table 02: Italy - Forecast for In-Vitro Diagnostics (IVD) Market Share by Test Types (Percent), 2023 - 2028
Table 03: Italy - In-Vitro Diagnostics (IVD) Market Share by Technology (Percent), 2018 - 2022
Table 04: Italy - Forecast for In-Vitro Diagnostics (IVD) Market Share by Technology (Percent), 2023 - 2028
Table 05: Italy - In-Vitro Diagnostics (IVD) Market Share by Products (Percent), 2018 - 2022
Table 06: Italy - Forecast for In-Vitro Diagnostics (IVD) Market Share by Products (Percent), 2023 - 2028
Table 07: Italy - In-Vitro Diagnostics (IVD) Market Share by Application (Percent), 2018 - 2022
Table 08: Italy - Forecast for In-Vitro Diagnostics (IVD) Market Share by Application (Percent), 2023 - 2028
Table 09: Italy - In-Vitro Diagnostics (IVD) Market Share by End User (Percent), 2018 - 2022
Table 10: Italy - Forecast for In-Vitro Diagnostics (IVD) Market Share by End User (Percent), 2023 - 2028

Companies Mentioned

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthineers
  • Danaher Corporation
  • Thermo Fisher Scientific
  • Sysmex Corporation

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...